Oetgen Stephen Duane

DirectorArxis, Inc. (ARXS) · full profile →Form 4 · filed Apr 20, 2026
Net Buying
Open-Market Buys
$700K
Open-Market Sells
$0
Net Open-Market Flow
$700K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 17, 2026Grant(A)5K$05K
Apr 17, 2026Buy(P)25K$28.00$700K30K

Transaction Codes

A
Grant / award
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-164673) within minutes of acceptance. Every field above traces to the original document. Verify it directly: